DK446287D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
DK446287D0
DK446287D0 DK446287A DK446287A DK446287D0 DK 446287 D0 DK446287 D0 DK 446287D0 DK 446287 A DK446287 A DK 446287A DK 446287 A DK446287 A DK 446287A DK 446287 D0 DK446287 D0 DK 446287D0
Authority
DK
Denmark
Prior art keywords
proteins
adjuvant
vaccine
picornavirus
poliovirus
Prior art date
Application number
DK446287A
Other languages
English (en)
Other versions
DK169276B1 (da
DK446287A (da
Inventor
Antonius Ludovicus Van Wezel
Antonius Gerardus Hazendonk
Eduard Coen Beuvery
Original Assignee
Nl Mini Welzijn Gesung Cultur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nl Mini Welzijn Gesung Cultur filed Critical Nl Mini Welzijn Gesung Cultur
Publication of DK446287D0 publication Critical patent/DK446287D0/da
Publication of DK446287A publication Critical patent/DK446287A/da
Application granted granted Critical
Publication of DK169276B1 publication Critical patent/DK169276B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32622New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK446287A 1986-08-27 1987-08-26 Vaccine indeholdende et immunogent virusprotein DK169276B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/900,739 US4946676A (en) 1986-08-27 1986-08-27 Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide
US90073986 1986-08-27

Publications (3)

Publication Number Publication Date
DK446287D0 true DK446287D0 (da) 1987-08-26
DK446287A DK446287A (da) 1988-02-28
DK169276B1 DK169276B1 (da) 1994-10-03

Family

ID=25413018

Family Applications (1)

Application Number Title Priority Date Filing Date
DK446287A DK169276B1 (da) 1986-08-27 1987-08-26 Vaccine indeholdende et immunogent virusprotein

Country Status (10)

Country Link
US (1) US4946676A (da)
EP (1) EP0257721B1 (da)
JP (1) JPS63132844A (da)
AT (1) ATE71534T1 (da)
CA (1) CA1292690C (da)
DE (1) DE3776034D1 (da)
DK (1) DK169276B1 (da)
ES (1) ES2032812T3 (da)
GR (1) GR3003754T3 (da)
NO (1) NO873593L (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797270B1 (en) * 1989-03-16 2004-09-28 Center For Blood Research, Inc. Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
CA2105629A1 (en) * 1992-09-14 1994-03-15 Robert S. Becker Potentiation of immunogenic response
EP1409551A4 (en) * 2001-06-21 2004-10-13 Uab Research Foundation CHEMICAL CAPSIDE PROTEINS AND USES THEREOF
US20040002058A1 (en) * 2001-06-21 2004-01-01 Uab Research Foundation Chimeric capsid proteins and uses thereof
US20090142364A1 (en) * 2007-08-30 2009-06-04 Fedor Alexandrovich Brovko Method for finding novel peptide immunostimulatory adjuvants, compositions and methods of use
WO2016205389A1 (en) 2015-06-15 2016-12-22 Emory University Multivalent enterovirus vaccine compositions and uses related thereto
JP7145083B2 (ja) * 2016-03-20 2022-09-30 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 高等植物の葉緑体におけるトランス遺伝子発現を増加させるためのコドン最適化及びリボソームプロファイリング

Also Published As

Publication number Publication date
US4946676A (en) 1990-08-07
GR3003754T3 (da) 1993-03-16
DK169276B1 (da) 1994-10-03
ES2032812T3 (es) 1993-03-01
EP0257721B1 (en) 1992-01-15
DK446287A (da) 1988-02-28
JPS63132844A (ja) 1988-06-04
EP0257721A3 (en) 1988-06-08
CA1292690C (en) 1991-12-03
NO873593D0 (no) 1987-08-26
NO873593L (no) 1988-02-29
ATE71534T1 (de) 1992-02-15
DE3776034D1 (de) 1992-02-27
EP0257721A2 (en) 1988-03-02

Similar Documents

Publication Publication Date Title
ATE258188T1 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
DE58906121D1 (de) Rekombinantes Vaccinia-Virus MVA.
ATE325882T1 (de) Polypeptide, die mit alfalfamosaikviralen oder ilarviralen kapsiden fusioniert sind
ATE115187T1 (de) Poxvirus-vektoren.
DE68924162T2 (de) Stressproteine und verwendungen dafür.
ES2002490A6 (es) Un metodo de preparar un virus recombinante
NO932423D0 (no) Ekspresjon av rekombinante proteiner i attenuerte bakterier
ATE364083T1 (de) Immunogene zusammensetzungen gegen eine helicobacterinfektion, verwendung von polypeptiden in diesen zusammensetzungen und nukleinsäurendie besagte polypeptide kodieren
ATE109830T1 (de) Expression von virusproteinen mit immunologischer aktivität.
DE3776034D1 (de) Vakzine.
KR890700030A (ko) 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
IL91609A0 (en) Allelic variants of plasmodium falciparum merozoite surface antigen
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
KR980000469A (ko) Hbv 항원단백질을 발현하는 키메라 폴리오바이러스 백신벡터를 이용한 면역화 방법

Legal Events

Date Code Title Description
A0 Application filed